4//SEC Filing
5AM Ventures IV, L.P. 4
Accession 0001209191-20-037714
CIK 0001781983other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 7:22 PM ET
Size
20.9 KB
Accession
0001209191-20-037714
Insider Transaction Report
Form 4
5AM Ventures IV, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-06-16$33.30/sh−4,807$160,073→ 75,965 total(indirect: See footnotes) - Sale
Common Stock
2020-06-16$33.30/sh−19,836$660,539→ 313,497 total(indirect: See footnotes) - Sale
Common Stock
2020-06-16$33.30/sh−115,357$3,841,388→ 1,823,192 total(indirect: See footnotes)
Footnotes (5)
- [F1]Shares are held directly by 5AM Ventures IV, L.P.
- [F2]5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.
- [F3]Shares are held directly by 5AM Co-Investors IV, L.P.
- [F4]Shares are held directly by 5AM Opportunities I, L.P. ("Opportunities"), which is under common control with the 5AM IV Funds. The 5AM IV Funds and Opportunities expressly disclaim status as a "group" for purposes of this Form 4.
- [F5]5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of the shares of Common Stock held directly by Opportunities, except to the extent of its or his pecuniary interest therein.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001589315
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 7:22 PM ET
- Size
- 20.9 KB